新開源(300109.SZ):全資子公司競得松江工業區一宗地塊土地使用權並簽訂土地出讓合同
格隆匯 8 月 5日丨新開源(300109.SZ)公告,全資子公司新開源(上海)醫療科技有限公司(以下簡稱“新開源(上海)”)於昨日參與了上海市松江區規劃和自然資源局以網上掛牌方式公開出讓的國有土地使用權競拍,根據上海市松江區規劃和自然資源局掛字202014303,新開源(上海)成功競得松江區工業區西區(松江區工業區V-46-4號(新城C02單元02B-06號)地塊)土地使用權並取得成交確認書。並與松江區規劃和自然資源局簽訂了《上海市國有建設用地使用權出讓合同》(電子監管號:172020002701)。
本次競拍取得的國有土地使用權將用於公司(松江)精準醫療產研基地建設,基地包括“基於基因測序的精準醫療技術平台建設項目”、“藥物篩選服務平台建設項目”、“全自動宮頸癌複合診斷系統建設項目”、“體外診斷試劑關鍵原料國產化項目”、“CAR-T全產業鏈全自主知識產權化項目”。基地將全面承擔BioVision產品臨牀轉化,集聚呵爾、三濟、晶能、華道等國內控(參)股公司研發及生產能力,進一步挖掘協同效應,為公司精準醫療業務長遠發展提供有力保障。該事項不會對公司未來財務狀況和經營成果產生不良影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.